Literature DB >> 7509990

Endothelin-1 promotes neointima formation after balloon angioplasty in the rat.

S A Douglas1, E H Ohlstein.   

Abstract

The long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA) is severely limited by the high incidence of vascular restenosis. Endothelin-1 (ET-1) has been implicated in the pathogenesis of this response, since circulating levels of this potent smooth-muscle mitogen are elevated after PTCA. Therefore, this study examined the effect of exogenous ET-1 administration on the development of stenotic lesions in the rat common carotid artery angioplasty model. Immediately after left common carotid artery balloon angioplasty, rats received a 30-min i.a. infusion of either saline vehicle (0.9% NaCl w/v) or ET-1 (17 pmol kg-1 min-1) via the left external carotid artery. Left and right common carotid arteries were removed 7 days later for quantitative image analysis. Balloon angioplasty caused significant neointima proliferation in left common carotid arteries, the extent of which was increased significantly by acute ET-1 treatment (approximately 65% greater neointima formation relative to saline-treated rats). ET-1 treatment had no effect on the geometry of contralateral right common carotid arteries. Therefore, these data support a role for ET-1 in the pathogenesis of vascular restenosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7509990     DOI: 10.1097/00005344-199322008-00097

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

Review 1.  The therapeutic potential of endothelin receptor antagonists in cardiovascular disease.

Authors:  M Barton; W Kiowski
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

2.  Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk.

Authors:  Katsuhito Yasuno; Mehmet Bakırcıoğlu; Siew-Kee Low; Kaya Bilgüvar; Emília Gaál; Ynte M Ruigrok; Mika Niemelä; Akira Hata; Philippe Bijlenga; Hidetoshi Kasuya; Juha E Jääskeläinen; Dietmar Krex; Georg Auburger; Matthias Simon; Boris Krischek; Ali K Ozturk; Shrikant Mane; Gabriel J E Rinkel; Helmuth Steinmetz; Juha Hernesniemi; Karl Schaller; Hitoshi Zembutsu; Ituro Inoue; Aarno Palotie; François Cambien; Yusuke Nakamura; Richard P Lifton; Murat Günel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

3.  Endothelin attenuates apoptosis in human smooth muscle cells.

Authors:  J R Wu-Wong; W J Chiou; R Dickinson; T J Opgenorth
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

Review 4.  The mechanisms of coronary restenosis: insights from experimental models.

Authors:  G A Ferns; T Y Avades
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

5.  SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.

Authors:  E H Ohlstein; P Nambi; S A Douglas; R M Edwards; M Gellai; A Lago; J D Leber; R D Cousins; A Gao; J S Frazee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 6.  Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics.

Authors:  M Barton
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 4.592

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.